Skip Nav Destination
Close
Article navigation
February 1995
Conference Abstract|
February 01 1995
Ym617, a New α1-Adrenoreceptor Antagonist: Pharmacokinetics(Pk) and Pharmacodynamics in Elderly Men with Benign Prostatic Hypertrophy(Bph)
C Castleden
C Castleden
*Leicester General Hospital
Search for other works by this author on:
Clin Sci (Lond) (1995) 88 (s32): 10P.
Citation
B Panayiotou, LO Tc, D Osborn, C Castleden; Ym617, a New α1-Adrenoreceptor Antagonist: Pharmacokinetics(Pk) and Pharmacodynamics in Elderly Men with Benign Prostatic Hypertrophy(Bph). Clin Sci (Lond) 1 February 1995; 88 (s32): 10P. doi: https://doi.org/10.1042/cs088010Pa
Download citation file:
Close
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
1
Views
0
Citations
Cited By
Related Articles
Immunogenicity, toxicology, pharmacokinetics and pharmacodynamics of growth hormone ligand–receptor fusions
Clin Sci (Lond) (August,2010)
Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia
Clin Sci (Lond) (February,1999)
Three spinach leaf nitrate reductase-3-hydroxy-3-methylglutaryl-CoA reductase kinases that are regulated by reversible phosphorylation and/or Ca 2+ ions
Biochem J (July,1997)
Using molecular simulation to explore the nanoscale dynamics of the plant kinome
Biochem J (March,2018)